Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Etomidate Injection
Status: Currently in Shortage
»Date first posted:
10/05/2022
»Therapeutic Categories: Anesthesia
Caplin Steriles, Ltd. (Reverified 04/02/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Etomidate, Injection, 2 mg/1 mL (NDC 65219-445-10) | Available | Check wholesalers for inventory; Marketed by Fresenius Kabi | |
| Etomidate, Injection, 40 mg/20 mL (NDC 65219-445-20) | Available | Check wholesalers for inventory; Marketed by Fresenius Kabi | |
| Etomidate, Injection, 2 mg/mL (NDC 65219-447-20) | Available | Check wholesalers for inventory; Marketed by Fresenius Kabi 800-551-7176 | |
| Etomidate, Injection, 2 mg/mL (NDC 72485-508-10) | Available | Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586 | |
| Etomidate, Injection, 2 mg/mL (NDC 72485-509-10) | Available | Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586 |
Eugia US LLC (Revised 03/18/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10) | Available | Check wholesalers for inventory | |
| Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20) | Available | Check wholesalers for inventory |
Gland Pharma Limited (Reverified 03/24/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10) | Available | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. | |
| Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10) | Available | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. |
Hikma Pharmaceuticals USA, Inc. (Reverified 02/14/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10) | Unavailable | Additional lots will be available in the March 2025 timeframe. Product will be made available as it is released. | Demand increase for the drug |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10) | Available | Additional lots will be available. Product will be made available as it is released. | |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10) | Pending information | Novaplus | |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10) | Pending information | Novaplus | |
| Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10) | Pending information | Distributed by Civica | |
| Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10) | Pending information | Distributed by Civica |
Hospira, Inc., a Pfizer Company (Revised 03/30/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01) | Unavailable | Next Delivery and Estimated Recovery: June 2025 | Other |
| Amidate, Injection, 2 mg/mL (NDC 0409-6695-02) | Limited Supply Available | Next Delivery and Estimated Recovery: June 2025 | Other |
Mylan Institutional, a Viatris Company (Reverified 03/20/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10) | Available | ||
| Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20) | Available |